Safinaz Şahin
Research Subjects
Safinaz Şahin has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Zafer Odabaş
Marmara University, Faculty of Science, Department of Chemistry, Istanbul 34722, Turkey
3 shared publications - Ali Rıza Özkaya
Department of Chemistry Faculty of Science Marmara University Istanbul Turkiye
2 shared publications - Muhammed Tilahun Muhammed
Department of Pharmaceutical Chemistry, Faculty of Pharmacy Suleyman Demirel University Isparta Turkey
2 shared publications - Özgün Akdağ
Department of Chemistry Istanbul Technical University 34469, Maslak Istanbul Turkey
2 shared publications - Ilgın Tuana Ateş1 shared publication
- İkBal Demet Nane
Isparta Uygulamali Bilimler Universitesi
1 shared publication
Latest Publications
- 5 August 2026
- Published by Elsevier in Journal of the Indian Chemical Society
- Vol. 103 (10)
Synthesis, cytotoxic evaluation and molecular modeling of 5-bromo-2-methoxyphenoxy substituted phthalonitriles and phthalic acids
- 5 August 2026
- Published by Elsevier in Journal of the Indian Chemical Society
- Vol. 103 (10)
Synthesis, cytotoxic evaluation and molecular modeling of 5-bromo-2-methoxyphenoxy substituted phthalonitriles and phthalic acids
- Open Access
- 10 February 2026
- Published by Elsevier in SSRN Electronic Journal
Fluorination Effects as distant substituents on Phthalonitrile and Phthalic Acid Derivatives: Cytotoxic Activity and Cathepsin X-Focused Docking and Molecular Dynamics Studies
In this study, a series of fluorinated and non-fluorinated phthalonitrile derivatives were synthesized via the reaction of 4-(tert-butyl)benzene-1,2-diol with tetrafluorophthalonitrile and 4,5-dichlorophthalonitrile under controlled conditions. Subsequent hydrolysis of the nitrile groups afforded the corresponding phthalic acid derivatives, enabling the systematic evaluation of substituent effects on biological activity. The molecular structures of all synthesized compounds were confirmed by FT-IR and ¹H NMR spectroscopy.The cytotoxic activities of the compounds were evaluated against human lung (A549), prostate (PC3), and breast (MCF-7) cancer cell lines, as well as normal fibroblast cells (L929), using the MTT assay. The compounds exhibited distinct cell line–dependent activity profiles; compound 3 showed the highest cytotoxic activity against the PC3 cell line, whereas compound 2 was the most active against A549 and MCF-7 cells. In addition, the antioxidant potential of the compounds was assessed using the DPPH radical scavenging assay, revealing moderate activity for the carboxylic acid derivatives.To elucidate the possible molecular mechanisms underlying the observed biological effects, molecular modeling studies were performed. Target fishing analysis suggested cathepsin X and tubulin as potential biological targets for the synthesized scaffolds. Molecular docking studies demonstrated a higher binding affinity of the compounds toward human cathepsin X compared to tubulin. Furthermore, molecular dynamics simulations confirmed the formation of stable ligand–protein complexes with cathepsin X, supporting the docking results. Overall, these findings indicate that the synthesized phthalonitrile-derived phthalic acid compounds, particularly compound 2, may serve as promising scaffolds for further development as cathepsin X–targeted anticancer agents.
- 10 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFluorination Effects as distant substituents on Phthalonitrile and Phthalic Acid Derivatives: Cytotoxic Activity and Cathepsin X-Focused Docking and Molecular Dynamics Studies
In this study, a series of fluorinated and non-fluorinated phthalonitrile derivatives were synthesized via the reaction of 4-(tert-butyl)benzene-1,2-diol with tetrafluorophthalonitrile and 4,5-dichlorophthalonitrile under controlled conditions. Subsequent hydrolysis of the nitrile groups afforded the corresponding phthalic acid derivatives, enabling the systematic evaluation of substituent effects on biological activity. The molecular structures of all synthesized compounds were confirmed by FT-IR and ¹H NMR spectroscopy.The cytotoxic activities of the compounds were evaluated against human lung (A549), prostate (PC3), and breast (MCF-7) cancer cell lines, as well as normal fibroblast cells (L929), using the MTT assay. The compounds exhibited distinct cell line–dependent activity profiles; compound 3 showed the highest cytotoxic activity against the PC3 cell line, whereas compound 2 was the most active against A549 and MCF-7 cells. In addition, the antioxidant potential of the compounds was assessed using the DPPH radical scavenging assay, revealing moderate activity for the carboxylic acid derivatives.To elucidate the possible molecular mechanisms underlying the observed biological effects, molecular modeling studies were performed. Target fishing analysis suggested cathepsin X and tubulin as potential biological targets for the synthesized scaffolds. Molecular docking studies demonstrated a higher binding affinity of the compounds toward human cathepsin X compared to tubulin. Furthermore, molecular dynamics simulations confirmed the formation of stable ligand–protein complexes with cathepsin X, supporting the docking results. Overall, these findings indicate that the synthesized phthalonitrile-derived phthalic acid compounds, particularly compound 2, may serve as promising scaffolds for further development as cathepsin X–targeted anticancer agents.